Detailed analyses revealed that OLFML3 expression in MSS CRC is higher than in MSI tumors, higher in grade 2–4 than in grade 1 tumors, and higher in the CMS4 subtype. This evidence concerns the gene OLFML3 and colorectal carcinoma.